Since SARS-CoV-2-triggered inflammation can activate NLRP3-inflammasome (6) and elevated NLRP3-inflammasome levels are a feature of AOSD (19), increased IL-1β levels were observed in both diseases. The gene discussed is NLRP3; the disease is adult-onset Still disease.